through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
For millions of people worldwide who live with asthma, getting a correct diagnosis has long been a frustrating journey. Traditional lung function tests can be difficult to perform, especially for young children, and may miss cases where a...
When you breathe out, you exhale more than just carbon dioxide and water vapor. Your breath carries trace amounts of nitric oxide (NO), a gas that serves as a biological messenger. For decades, doctors have used a simple breath test calle...
Uric acid often gets a bad rap, synonymous with the excruciating pain of gout. But in reality, it’s a normal and even beneficial compound in our bodies. The trouble begins when there’s too much of it. So, how is uric acid crea...
Please complete the form to contact our team